Melissa Purcell, an Australian nurse working in an intensive care in London, is at a higher risk of contracting the infection.
In fact, Ms. Purcell caught the virus earlier this year.
She said that she has some antibodies. However, she is not sure how long the protection would be.
As a frontline health worker, she could be among the first recipients of the Pfizer.BioNTech vaccine that will be distributed across Britain on Tuesday.
Ms. Purcell said that she’ll be ready to accept the offer.
She admitted that when she first learned about the Pfizer vaccine, she was worried about the process, and receiving it firsthand means that she could readily be exposed to its side effects.
Meanwhile, she still expressed her support to the government in their steps of taking action to suppress the COVID-19 pandemic.
Ms. Purcell said that it had been a tough year for people like her that work on COVID wards.
She said that it’s hard to see young people not survive the virus.
Despite the multiple layers of protective gear she wears, the risk is still there.
She admitted that there are times that she felt nervous about going home after working hours in the hospital.
The vaccine, she believes, could change that.
She pointed out that when the vaccines are distributed, she and her colleagues can go home feeling much safer.
‘Touch wood’
Londoner Kathleen Briley, 92 years of age, is in the age range of the first recipients of the Pfizer/BioNTech vaccine.
She said that she’s in line for it.
Ms. Briley said that she was fed up after nine months of recurring lockdowns and the arrival of the vaccine is a glimpse of hope that it’ll end.
However, despite the vaccine’s approval by the UK’s Medicines and Healthcare Regulatory Agency, there are people that remain unconvinced that it is unsafe.
Stephen Lindsay is one of them. He said that it might affect his plans to travel overseas in the meantime.